Beta-thalassemia
Open accessThe DOI matches its Crossref record; 4 of the 89 references it cites were found in a registry or an index, and 85 are not checked yet.
Abstract
Beta-thalassemia is caused by the reduced (beta) or absent (beta) synthesis of the beta globin chains of the hemoglobin tetramer. Three clinical and hematological conditions of increasing severity are recognized, i.e., the beta-thalassemia carrier state, thalassemia intermedia, and thalassemia major. The beta-thalassemia carrier state, which results from heterozygosity for beta-thalassemia, is clinically asymptomatic and is defined by specific hematological features. Thalassemia major is a severe transfusion-dependent anemia. Thalassemia intermedia comprehend a clinically and genotypically very heterogeneous group of thalassemia-like disorders, ranging in severity from the asymptomatic carrier state to the severe transfusion-dependent type. The clinical severity of beta-thalassemia is related to the extent of imbalance between the alpha and nonalpha globin chains. The beta globin (HBB) gene maps in the short arm of chromosome 11, in a region containing also the delta globin gene, the embryonic epsilon gene, the fetal A-gamma and G-gamma genes, and a pseudogene (psiB1). Beta-thalassemias are heterogeneous at the molecular level. More than 200 disease-causing mutations have been so far identified. The majority of mutations are single nucleotide substitutions, deletions, or insertions of oligonucleotides leading to frameshift. Rarely, beta-thalassemia results from gross gene deletion. In addition to the variation of the phenotype resulting from allelic heterogeneity at the beta globin locus, the phenotype of beta-thalassemia could also be modified by the action of genetic factors mapping outside the globin gene cluster and not influencing the fetal hemoglobin. Among these factors, the ones best delineated so far are those affecting bilirubin, iron, and bone metabolisms. Because of the high carrier rate for HBB mutations in certain populations and the availability of genetic counseling and prenatal diagnosis, population screening is ongoing in several at-risk populations in the Mediterranean. Population screening associated with genetic counseling was extremely useful by allowing couples at risk to make informed decision on their reproductive choices. Clinical management of thalassemia major consists in regular long-life red blood cell transfusions and iron chelation therapy to remove iron introduced in excess with transfusions. At present, the only definitive cure is bone marrow transplantation. Therapies under investigation are the induction of fetal hemoglobin with pharmacologic compounds and stem cell gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload
Anderson, L. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2822 · Cited by 1,682
Common West African HLA antigens are associated with protection from severe malaria
Hill, A. V. S., Allsopp, C. E. M., Kwiatkowski, D., Anstey, N. M., Twumasi, P., Rowe, P. A., Bennett, S., Brewster, D., McMichael, A. J., & Greenwood, B. M. (1991) · Nature · doi:10.1038/352595a0 · Cited by 1,552
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
Ganz, T. (2003) · Blood · doi:10.1182/blood-2003-03-0672 · Cited by 1,544
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin
Hanna, J., Wernig, M., Markoulaki, S., Sun, C.-W., Meissner, A., Cassady, J. P., Beard, C., Brambrink, T., Wu, L.-C., Townes, T. M., et al. (2007) · Science · doi:10.1126/science.1152092 · Cited by 1,202
Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria
McGuire, W., Hill, A. V. S., Allsopp, C. E. M., Greenwood, B. M., & Kwiatkowski, D. (1994) · Nature · doi:10.1038/371508a0 · Cited by 1,169
Rund, D., & Rachmilewitz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050436 · Cited by 939
Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H. (2008) · Science · doi:10.1126/science.1165409 · Cited by 919
Research works printed but not linked: 5
- Wheatherall DJ, Clegg JB. The thalassemia syndromes. 4th ed. Oxford, England: Blackwell Science Ltd, 2001.
- Weatherall DJ, Clegg JB, Higgs DR, Wood WG. The hemoglobinopathies. In: Scriver CR, Beaudet Al, Sly WS, Valle D, Vogelstein B, editors. The metabolic and molecular bases of inherited disease (OMMBID). Chapter 101. New York, NY: McGraw-Hill, 2002. Available at: www.ommbid.com. Accessed December 31, 2007.
- Rees, 1998, Genetic influenes on bone disease in thalassemia, Blood, 92, S532a
- Dresner Pollak, 2000, Bone mineral metabolism in adults with beta thalassemia major and intermedia, Br J Haematol, 111, 902
- Galanello, 1990, Deletion delta-thalassemia: the 7.2 kb deletion of Corfu delta beta-thalassemia in a non-beta-thalassemia chromosome, Blood, 15, 75:11747
Cited by
Items 601–700 of 721
Anästhesie bei Erkrankungen des Bluts
Waschke, K. F. (2012) · Springer eBooks · doi:10.1007/978-3-642-21125-6_69
Ginzburg, Y. Z., & Shaz, B. H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397164-7.00070-7
Personalized Medicine and Blood Disorders
Zhang, L. (2016) · Personalized Medicine · doi:10.2217/pme-2016-0043 · Cited by 2
Clinical Applications of Stem Cells in Women’s Reproductive Health
Mousa, N. A., Shazly, S. A., & Nassr, A. A. (2016) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-29149-9_6
2 Cases of Beta-thalassemia Minor in Korea
Kim, E. J., Jeung, S. W., & Yoon, H. S. (2017) · Imsang soa hyeoraek jong-yang/Imsang soa hyeol'aeg jong'yang/Clinical pediatric hematology-oncology · doi:10.15264/cpho.2017.24.2.136
Vinciguerra, M., Passarello, C., Cassarà, F., Leto, F., Cannata, M., Ferro, E., Anzà, D., Calvaruso, G., Maggio, A., & Giambona, A. (2017) · Hematology · doi:10.1080/10245332.2017.1403737
CARACTERIZAÇÃO CLÍNICA DOS PACIENTES COM HEMOGLOBINOPATIA ATENDIDOS NO HEMOCENTRO DE SERGIPE
Andrade, M. L., Reis, A. A. D. V. O., Marinho, L. A. D. H., de Melo, E. V., & Porto, M. A. D. A. [. (2018) · Arquivos Catarinenses de Medicina · doi:10.63845/xz8cpt86
Sickle Cell Anemia: A review on the most severe form of Sickle Cell Disease
Paredes, M. B., & Sulen, M. E. (2019) · Bionatura · doi:10.21931/rb/cs/2019.02.01.19
Nigam, N., Verma, N., Agrawal, M., Gupta, H., Singh, P. K., Deo, S., & Saxena, S. K. (2019) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2019/746
Biomaterials for gene editing therapeutics
Shim, G., Kim, D., Le, Q., Byun, J., Park, J.-W., & Oh, Y. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-102983-1.00008-9
Dutta, S., Biswas, A., Choudhury, P., Bakshi, S., Chowdhury, P. K., Bhattacharyya, M., Chakraborty, S., Dutta, S., & Sadhukhan, P. C. (2020) · medRxiv · doi:10.1101/2020.05.06.20092049
HamaSalih, R. M., & Al-Nimer, M. S. M. (2020) · Journal of Sulaimani Medical College · doi:10.17656/jsmc.10246
When Hemoglobin Reported to Be A, S, and F Are Neither A, S, Nor F: A Tale of Two Patients
Harris, N., Kavesh, M. H., Beal, S. G., Winter, W. E., & Chui, D. H. K. (2020) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfaa087
Poon, K., & Tan, K. M. L. (2020) · Pathology · doi:10.1016/j.pathol.2020.08.022
Shehryar, M., Aslam, M., Sohail, N., Qadeer, S., & Tariq, T. (2020) · Pakistan BioMedical Journal · doi:10.52229/pbmj.v2i2.17
Chen, X., Lin, Z., Hu, J., Chen, S., Wen, S., Ai-zhu, W., Wu, H. W., Huang, J., Wang, H., Sun, J., et al. (2021) · Hemoglobin · doi:10.1080/03630269.2021.1883646
Noninvasive Prenatal Diagnosis and Screening for Monogenic Disorders Using Cell‐Free DNA
den Veyver, I. B. V., Chandler, N. J., & Chitty, L. S. (2021) · Wiley eBooks · doi:10.1002/9781119676980.ch8
The Newborn with Hematologic Abnormalities
Maxwell, R. R., Driscoll, M. C., & Manwani, D. G. (2020) · American Academy of PediatricsItasca, IL eBooks · doi:10.1542/9781610022255-28
Impact of new chelating agents on ocular abnormalities in β-thalassemia major patients
Abo-Zied, S., Elgemaey, H. M., & Abd-Aal, H. (2021) · Alexandria Journal of Pediatrics · doi:10.4103/ajop.ajop_33_21
118 2 ストローク火花点火機関における圧縮天然ガス掃気孔噴射運転の最適化
Maehara, M., 中島, 邦., 内山, 浩., 志賀, 聖., 荒木, 幹., 中村, 壽., & 小保方, 富. (2003) · 日本機械学会関東支部ブロック合同講演会講演論文集
DNA Repair Pathways in the Context of Therapeutic Genome Editing
Wimberger, S., Akrap, N., & Taheri‐Ghahfarokhi, A. (2022) · Wiley eBooks · doi:10.1002/9781119671404.ch13
EPIDEMIOLOGY OF DOWN’S SYNDROME & Β- THALASSEMIA IN INDIA
Gajbhiye, N., & Gaitonde, R. U. (2022) · International Journal of Research -GRANTHAALAYAH · doi:10.29121/granthaalayah.v10.i2.2022.4515
Beta-Thalassemia major with Gaucher disease
Ibrahimi, M. A., Hakimi, T., & Halimi, S. A. (2022) · International Journal of Surgery Open · doi:10.1016/j.ijso.2022.100460
Templeton, A. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-386025-5.00009-9
Barmpouti, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-03568-6_5
(2012) · Springer eBooks · doi:10.1007/978-1-4614-1037-9_227
Shenoy, N. K., & Cordero, H. (2018) · Springer eBooks · doi:10.1007/978-3-319-68379-9_17
Chen, H. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6430-3_227-2
Anästhesie bei Patienten mit Anämien, Polyzythämien und Methämoglobinämie
Waschke, K. F. (2016) · Springer eBooks · doi:10.1007/978-3-662-45539-5_108-1
Chen, H. (2017) · Springer eBooks · doi:10.1007/978-1-4939-2401-1_227
(2016) · Elsevier eBooks · doi:10.1016/b978-0-323-39252-5.50222-5
Dynamic Thiol-Disulfide Homeostasis in Children With β-Thalassemia Trait
Kurucu, B., Fettah, A., Çapkınoğlu, E., Öner, N., Eren, F. K., Erel, Ö., Yeşil, Ş., & Şahin, G. (2022) · Hemoglobin · doi:10.1080/03630269.2022.2070073
Թալասեմիաների ընդհանուր բնութագիրը
Գրիգորյան, Հ. Ա., Հակոբյան, Լ. Ս., Քրմոյան, Լ. Մ., Դանելյան, Ս. Հ., & Վաղարշակյան, Լ. Հ. (2022) · Medical Science of Armenia · doi:10.54503/0514-7484-2022-62.2-20
Luo, H., Tan, S., Li, W., Zhou, S.-X., Ni, L., Yang, Y.-Q., Zhang, X., Huang, P., Yi, H., & Yang, X. (2022) · doi:10.22541/au.165500141.10145919/v1
Habbash, F., Al-Bati, W., Alhashim, H. W., Aldossari, M., Alali, A., Alalyani, K., Al-Ebrahim, Z., Eraqi, S., Binayfan, Z., Almarri, A., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1867172/v1
Thrombocytosis in Thalassemia majorPreprint
Naeem, M., Aamir, M., Ijaz, F., & Amin, N. (2022) · Research Square · doi:10.21203/rs.3.rs-1998089/v1
Kalai, M., Moumni, I., Ouragini, H., Fraj, I. B., Mellouli, F., Ouederni, M., Chaouachi, D., Boudriga, I., & Menif, S. (2022) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/00045632221134688
Zhang, W., Li, X., Wu, X., Huang, X., Zhang, X., Lu, Y., Niu, J., & Zhang, J. (2022) · Medicine · doi:10.1097/md.0000000000031645
Elgawhary, S. M., Mohammed, M. N., Ahmed, H. M., Elamir, A. M., & Abdelaziz, H. M. (2022) · The Egyptian Journal of Haematology · doi:10.4103/ejh.ejh_13_22
SMPD1 gene variants in patients with β-Thalassemia major
Dursun, F. E., & Özen, F. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08275-x
Calleja, Á. M. M., Lourenço, M., Macedo, M. L., Gaspar, R. R., Ribeiro, L., & Santos, A. L. (2023) · Research Square · doi:10.21203/rs.3.rs-2591410/v1
Ghalib, A., Khan, V., Shams, S., & Pervaiz, R. (2023) · Arab Gulf Journal of Scientific Research · doi:10.1108/agjsr-01-2023-0016
Islam, N. N., Das, S. C., Hossain, M., Seuti, S. A., Sultana, R., & Chowdhury, M. A. (2023) · Bangladesh Medical Research Council Bulletin · doi:10.3329/bmrcb.v48i3.63809
Samanta, A., & Bhattacharyya, N. (2023) · Asian Journal of Pharmaceutical Research and Health Care · doi:10.4103/ajprhc.ajprhc_37_23 · Cited by 1
‘Ulya, N. M., Indrawati, V. N., Wulansari, W. T., Lesmana, I., & Handayani, N. S. N. (2023) · Hemoglobin · doi:10.1080/03630269.2023.2244429
Estudio de la talasemia β en el laboratorio clínico: estrategias diagnósticas
López‐Escribano, H., & Martí-Martínez, A. (2023) · Revista de Medicina de Laboratorio · doi:10.20960/revmedlab.00194
Thanh, L. D. T., Quy, Q. D. B., Thu, H. P., Trung, K. N., Hữu, D. N., Thu, H. N., Mai, H. N. T., Thi, N. N., Thu, H. L., & Viet, T. L. (2023) · Nephro-Urology Monthly · doi:10.5812/numonthly-136753
Case Report of a Child with Beta Thalassemia Major in a Tribal Region of India
Neha, C., Narayan, P., Mahesh, N., & Manisha, S. (2023) · Journal of Child Adult Vaccines and Immunology · doi:10.29328/journal.jcavi.1001011
Application of CRISPR-Cas12a technology in zebrafish to simulate ß-globin gene (HBB) mutationsPreprint
Shafique, F., Ali, S., Balckburn, E., & Hassan, M. U. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.21.558926
Antenatal screening for Thalassemia minor among conceiving females: A preventive measure
Mehmood, S., Yousuf, P., Shaiq, P. A., Khalil, S., & Habiba, U. (2023) · International Journal of Clinical Biochemistry and Research · doi:10.18231/j.ijcbr.2023.033
Beta Thalassemia Presenting with Neonatal Cholestasis and Extensive Hemosiderosis: A Case Report
Jung, C. G., Lee, J. H., & Kim, Y. B. (2023) · Neonatal Medicine · doi:10.5385/nm.2023.30.4.102
Impact of Anemia in Development of Infants: A Review
Thakur, H., Tiwari, A. K., Kumar, A., Mishra, P. K., & Kumar, U. (2024) · ACTA SCIENTIFIC MICROBIOLOGY · doi:10.31080/asmi.2024.07.1345
ORTHODONTIC MANAGEMENT OF THALASSEMIA INTERMEDIA – A CASE REPORT
Deshmukh, S. V., Kharche, A., & Toshniwal, N. G. (2024) · BULLETIN OF STOMATOLOGY AND MAXILLOFACIAL SURGERY · doi:10.58240/1829006x-2024.1-150
Withdrawn: Phytocompounds Targeting for the Treatment of β-Thalassemia: A ReviewPreprint
Ghosh, S. (2024) · Preprints.org · doi:10.20944/preprints202406.0604.v1
Tùng, B. T., Trang, V. T. T., & Anh, N. T. V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-16013-4.00004-x · Cited by 1
Screening of thalassemia minor in the first and second trimesters of pregnancy
Abichandani, L. G., & Chandel, R. (2024) · International Journal of Recent Innovations in Medicine and Clinical Research · doi:10.18231/j.ijrimcr.2024.042
Jacob, R. B., Princess, A., Eze, E. M., & Jeremiah, Z. A. (2024) · SANAMED · doi:10.5937/sanamed0-51359
Jensen, K. N., Hammer, A., Khatib, A., & Hazin, M. (2024) · Cureus · doi:10.7759/cureus.74431
Perspective Chapter: Advances in Diagnosis of Beta Thalassemia Major
Demirbaş, Z. E. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1007915 · Cited by 1
Reddy, P. S., Locke, M., & Badawy, S. M. (2024) · doi:10.2196/preprints.69584
Das, D. A., Khuntia, I., Behera, S., baa, J., Routray, P., & Misra, S. (2024) · Indian Journal of Clinical and Experimental Ophthalmology · doi:10.18231/j.ijceo.2024.114
Shah, S. R. (2025) · Advances in Biomedical and Health Sciences · doi:10.4103/abhs.abhs_27_24
Other Topics Studied by Evolutionary Medicine
Libertini, G., Corbi, G., Shubernetskaya, O. S., Komici, K., & Ferrara, N. (2024) · Advances in studies of aging and health · doi:10.1007/978-3-031-84877-3_9
Safwan, M., Bourgleh, M. S., Alsudays, A. I., & Haider, K. H. (2025) · World Journal of Cardiology · doi:10.4330/wjc.v17.i2.103733
Diseases Deriving from Alterations of the Genotype
Libertini, G., Corbi, G., Shubernetskaya, O. S., Komici, K., & Ferrara, N. (2024) · Advances in studies of aging and health · doi:10.1007/978-3-031-84877-3_2
CRISPR/Cas9 gene editing for treating gene and protein disorders
Umeyor, C. E., Negi, P., Agarwal, R., Hanjankar, S. N., & Patravale, V. B. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27416-9.00004-6
Sha, W., Wang, X., Zhu, Y., Xie, F., Ihnaini, B., & Abdalla, H. B. (2024) · International Symposium on Computer Science and Intelligent Control (ISCSIC) · doi:10.1109/iscsic64297.2024.00032 · Cited by 1
Comprehensive analysis of sickle β+-thalassemia genotypes and their associated HbA levels in France
Baltus, C., Moutereau, S., Couque, N., Allaf, B., Giansily‐Blaizot, M., Boutin, J., Lee, K., Bernit, E., Cadet, E., Bobée, V., et al. (2025) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2025.102923
Kosta, S., Bhandari, S., Sahu, R., Joshi, P., & Bhandari, V. (2025) · Molecular Genetics and Genomics · doi:10.1007/s00438-025-02245-7
Multifocal Keratitis in 23-year-old Woman with β-Thalassemia
Asti, A. K., & Zuhria, I. (2025) · Vision Science and Eye Health Journal · doi:10.20473/vsehj.v4i2.2025.50-54
Evaluation of Beta Globin Gene Mutations in Mersin, Turkey: A Single Center Experience
Altıntaş, Z. M., & Eras, N. (2025) · Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi · doi:10.47572/muskutd.1621921
EFFECTIVENESS OF ART THERAPY ON SELF-ESTEEM IN CHILDREN WITH THALASSEMIA
Saba Bukhari, D. M. A. (2025) · Contemporary Journal of Social Science Review · doi:10.63878/cjssr.v3i1.439
Santhakumar, S., Stephen, L., Nellickal, A. J., Kulkarni, U. P., George, B., Mathews, V., & Edison, E. S. (2025) · The Indian Journal of Medical Research · doi:10.25259/ijmr_1589_2024 · Cited by 1
Szamosi, B. (2025) · Traditiones · doi:10.3986/traditio2025540201
Aziz, O. A., Shabana, A. H., Reyad, H. M., Elhawary, E. E., & Elagamy, O. A. (2025) · The Egyptian Journal of Haematology · doi:10.4103/ejh.ejh_26_25
Samanta, A., Pan, P., Payra, S. K., & Bhattacharyya, N. (2025) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/3424 · Cited by 1
Das, S., Purohit, P., Burma, S. P., Pradhan, S., Naik, A., Mohanty, S., Nayak, J., Behera, S. K., Patro, M. K., & Choudhury, S. (2025) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-025-02183-9
Reddy, P. S., Locke, M., & Badawy, S. M. (2025) · JMIR Pediatrics and Parenting · doi:10.2196/69584
Meloni, A., Saba, L., Positano, V., Pistoia, L., Fotzi, I., Marco, E. D., Sanna, P. M. G., Giovangrossi, P., Gerardi, C., Barone, A., et al. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.134025
Blood that was far from red: hypertriglyceridaema thalassaemia syndrome: case report
Priya, P. S., Mathews, I. M., Srinivasan, R., & Prakash, A. (2025) · Paediatrics and International Child Health · doi:10.1080/20469047.2025.2583690
Deep Vein Thrombosis in a Patient With Thalassemia Minor: A Case Report
Basnet, A., Acharya, B., Shrestha, M., & Thapa, S. (2025) · Clinical Case Reports · doi:10.1002/ccr3.71497
Rouzbehan, S., gorjaei, S. R., Ghasemi, M. J., & Shafiee, S. M. (2025) · مجله دانشگاه علوم پزشکی تربت حیدریه · doi:10.61882/jmsthums.13.2.56
Rostami, T., Kasaeian, A., Maleki, N., Nikbakht, M., Kiumarsi, A., Tavangar, S. M., Taheri, A. P. H., Mousavi, S. A., & Ghavamzadeh, A. (2021) · Figshare · doi:10.6084/m9.figshare.14337462
Modern therapeutic approaches for β-thalassemia: from blood transfusion to gene therapy
Dolgushina, E. N., Коптева, О. С., Shakirova, A. L., Lepik, K. V., Bykova, T. A., Zubarovskaya, L. S., & Kulagin, A. (2026) · Russian Journal of Pediatric Hematology and Oncology · doi:10.21682/2311-1267-2025-12-3-56-67
Alterations in Serum MAO Activity and Tau Levels in β-Thalassemia
Yağmur, I., Kurutaş, E. B., & Öner, E. (2026) · Hemoglobin · doi:10.1080/03630269.2026.2621350
Yapa, C. N., Weerakoon, N. N., Tillakeratne, T. N., & Amarasinghe, G. S. (2026) · BMC Research Notes · doi:10.1186/s13104-026-07688-8
Ye, Q. Q., Zhou, X., Yang, G., Xie, W. T., Yu, A. Y., & Duan, H. Z. (2026) · Annals of Hematology · doi:10.1007/s00277-026-06857-w
Meloni, A., Pistoia, L., Zerbini, M., Renne, S., Peritore, G., Fina, P., Vallone, A., Positano, V., Longo, F., Spasiano, A., et al. (2026) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-026-03646-4
Difficult Cases in the Diagnosis of Thalassemia Syndromes
Canatan, D., & Altunsoy, E. (2026) · Hemoglobin · doi:10.1080/03630269.2026.2627028
A novel HBD gene mutation associated with normal-range hb A2 in β-thalassemia carriers
Zhang, L., Yang, J., Li, X., Liu, Y., Liu, C., Duan, S., Zhang, L., Liu, W., & Chang, M. (2026) · Annals of Hematology · doi:10.1007/s00277-026-06892-7
Zaman, M., Danial, M., Mumtaz, S., Ivković, N., Uroš, V., & Akhunzada, A. (2025) · International Conference on Computer and Applications (ICCA) · doi:10.1109/icca66035.2025.11430941
Mutation Spectrum of Beta Thalassemia Trait in a Government Medical Hospital in New Delhi, India
Zaidi, M., Kumar, M., Shukla, S., & Goyal, R. (2026) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-025-02315-1
Metabolic fueling of hematopoietic stem cell differentiation to the erythroid lineage
Oburoglu, L. (2014) · theses.fr (ABES) · doi:10.70675/2a8ca582z1bd3z4b90z96c1z5964d1e426b9
Le rôle de l'érythroferrone dans la régulation du métabolisme du fer
Sardo, U. (2020) · theses.fr (ABES) · doi:10.70675/d03e67aczc44bz4af9z8fa1zef080668f44f
Biological functions of heme-sensitive polyreactive antibodies
Noé, R. (2022) · theses.fr (ABES) · doi:10.70675/fcec11d4z20fbz4ac2z8e13z8e5854e24ffe
Base editing approaches for the treatment of ß-hemoglobinopathies
Hardouin, G. (2022) · theses.fr (ABES) · doi:10.70675/593cd291z9d0ez45a6z82cdz64ffb2e65ff8
Genome and epigenome editing approaches to treat β-hemoglobinopathies
Fontana, L. (2024) · theses.fr (ABES) · doi:10.70675/f1623d8bz5529z4d2dzb255z45ed273f643c
Cohrt, K. O., & O’Dea, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083384
Elhadad, A. A. E. M., Mesbah, B. E.-D. M., Elfiky, S. M., & Hassan, S. S. N. (2026) · Alexandria Journal of Pediatrics · doi:10.4103/ajop.ajop_3_26
Rosser, C. A., Markham, T. E., & Codd, R. (2026) · Chemistry - A European Journal · doi:10.1002/chem.71115
Metadata
- Authors
- Cao, A., & Galanello, R.
- Affiliations
- National Research Council (IT)
- University of Cagliari (IT)
- Corresponding author
- Cao, Antonio
- Venue
- Genetics in Medicine
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 12
- Issue
- 2
- Pages
- 61-76
- ISSN
- 1098-3600 (ISSN-L)
- OpenAlex
- W4210970197
- Cited by
- 722
- References
- 4
- Citations by year
- 2026: 43 · 2025: 48 · 2024: 63 · 2023: 61 · 2022: 60 · 2021: 66 · 2020: 69 · 2019: 64 · 2018: 48 · 2017: 58 · 2016: 52 · 2015: 24 · 2014: 14 · 2013: 20 · 2012: 15
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4370 d)
- Locations
- Genetics in Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- beta-thalassemia, beta-globin gene, HBB mutations, thalassemia major, thalassemia intermedia, transfusion-dependent anemia, iron chelation therapy, bone marrow transplantation, fetal hemoglobin induction, genetic counseling, prenatal diagnosis, chromosome 11
- MeSH terms
- Female, Multigene Family, Genetic Testing, Globins, Genetic Carrier Screening, Humans, Pregnancy, Prenatal Diagnosis, Bone Marrow Transplantation, beta-Thalassemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.